CareDx expands NGS Transplant Product Offerings
Under the agreement,
“CareDx is uniquely positioned to provide genomic information to transplant patients to enable personalized medicine in this high need, high cost population. We continue to deliver on our promise to bring next generation sequencing solutions to the transplant clinic,” said
For more information, please visit: www.CareDx.com.
Forward Looking Statements
This press release contains forward-looking statements about our business, research, development and commercialization efforts, including statements regarding the development and commercialization of future NGS products and our ability to bring next generation sequencing solutions to the transplant clinic. These forward-looking statements are based upon information that is currently available to us and our current expectations, speak only as of the date hereof, and are subject to numerous risks and uncertainties, including risks associated with successful research, development and planned commercialization of our technologies, that are described in our filings with the
Chief Commercial Officer
Integrated Corporate Relations, Inc.
Source: CareDx, Inc.